Celiac disease-once believed to be rare-actually affects up to 1% of the US population. So underdiagnosed is the problem that the National Institutes of Health convened a consensus panel, which recently announced recommendations for appropriate diagnosis and management of the disease.
Celiac disease-once believed to be rare-actually affects up to 1% of the US population. So underdiagnosed is the problem that the National Institutes of Health convened a consensus panel, which recently announced recommendations for appropriate diagnosis and management of the disease.
Diagnosis of celiac disease may take up to 10 years because symptoms-diarrhea, abdominal cramping, pain, and distention-are relatively common complaints. In addition, other effects like persistent elevation of transaminases, short stature, delayed puberty, iron-deficiency anemia, recurrent fetal loss, and infertility can lead physicians down many incorrect diagnostic paths.
Once the disease is suspected, the first step is serologic testing with either antihuman tissue transglutaminase IgA or endomysial antibody immunofluorescence IgA. Both tests have equivalent diagnostic accuracy with high sensitivity and specificity, according to the NIH panel. If a patient tests positive, the next step is to obtain biopsy specimens of the proximal small bowel.
Mitka M. Higher profile needed for celiac disease: underdiagnosis fosters treatment delays, says panel. JAMA. 2004;292:913-914.
Unlocking HPV prevention: Insights from 2022 data on vaccination trends
May 14th 2024Explore the latest findings revealing vaccination rates among children aged 9 to 17 years, uncovering demographic disparities and highlighting the crucial role of vaccination in combating human papillomavirus infections and related health risks.
Read More
Prenatal cannabis and nicotine use linked to adverse pregnancy outcomes
May 14th 2024A recent study highlights the heightened risks of maternal and neonatal morbidity and mortality associated with combined cannabis and nicotine use during pregnancy, urging further investigation into their impact on short- and long-term outcomes.
Read More
Understanding pediatric STIs: Trends, management, and more
May 10th 2024Dive into the rising prevalence of sexually transmitted infections among adolescents and young adults, exploring educational gaps, vaccination rates, and the imperative need for open conversations between patients and health care providers to combat stigma and enhance preventive care.
Read More
No link found between antenatal corticosteroids and child neurodevelopment
April 25th 2024A recent study found no link between antenatal corticosteroid administration and adverse neurodevelopmental outcomes in children aged 6 years or older, offering reassurance for late preterm delivery practices.
Read More